GlassScriptPhysician profile
Julia Hyunju Lee
NPI 1215982350
$5,749.91
in general payments reported to CMS, 2019-2025
45 companies · $658 in 2025
The $658 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $361 · 2021: $1,168 · 2022: $980 · 2023: $644 · 2024: $711 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.84 |
| Education | $104.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hill-Rom Services, INC | $650.00 | 2019 | |
| Astellas Pharma US INC | $518.27 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $399.96 | 2019-2022 | |
| Myovant Sciences INC. | $324.23 | 2021-2022 | |
| Exeltis, USA INC. | $310.01 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $292.01 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $287.21 | 2023-2025 | Myfembree |
| Organon LLC | $261.16 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $249.36 | 2021-2025 | |
| Coopersurgical, INC. | $195.48 | 2019-2025 | Paragard T 380a, Supercut Hysterectomy Scissors |
| Pfizer INC. | $190.29 | 2020-2025 | |
| Conmed Corporation | $171.67 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $161.43 | 2021 | |
| Therapeuticsmd, INC. | $158.91 | 2019-2022 | |
| Exact Sciences Corporation | $146.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $127.91 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.90 | 2019-2025 | |
| Channel Medsystems, INC. | $117.80 | 2022 | |
| Olympus America INC. | $117.14 | 2019 | |
| Evofem Biosciences, INC. | $99.02 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $75.07 | 2021-2022 | |
| Agile Therapeutics, INC. | $69.42 | 2022-2023 | Twirla |
| Avion Pharmaceuticals | $55.05 | 2019-2022 | |
| Becton, Dickinson and Company | $52.81 | 2023 | Arista Ah Flexitip |
| Shield Therapeutics INC | $50.24 | 2023-2024 | Accrufer |
| Sanara Medtech INC. | $42.47 | 2025 | Celleraterx |
| Daiichi Sankyo INC. | $39.54 | 2019-2020 | |
| Applied Medical Resources Corporation | $37.38 | 2022 | |
| Lupin INC. | $36.90 | 2020 | |
| Millicent US INC | $36.01 | 2025 | Femlyv |
| Optumhealth Care Solutions, LLC | $34.77 | 2023-2025 | Vivify Health Care Team Portal, Zyno Solutions, Eitan Medical |
| Merck Sharp & Dohme LLC | $32.97 | 2021-2023 | Gardasil 9 |
| Amgen INC. | $30.30 | 2021 | |
| Gynesonics, INC. | $28.42 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $28.29 | 2019 | |
| Axsome Therapeutics, INC. | $28.07 | 2025 | Auvelity |
| Meditrina | $27.18 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.34 | 2022 | |
| Radius Health, INC. | $23.53 | 2024 | Tymlos |
| Sage Therapeutics, LLC | $21.09 | 2024 | |
| Baxter Healthcare | $19.75 | 2023 | Tisseel |
| Dexcom, INC. | $19.34 | 2023 | Dexcom G6 Transmitter |
| Si-Bone, INC. | $16.57 | 2020 | |
| Lilly USA, LLC | $16.25 | 2025 | Zepbound |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.